drugset / Trial / NCT05667805

Coagulation in Cirrhosis

NCT05667805

Phase 4 Recruiting 400 enrolled Medical University of Vienna
RandomizedParallel-groupSingle-blindTreatment

Summary

Out of fear of bleeding, liver cirrhosis patients are often treated prophylactically with blood and coagulation products before minor interventions. The COUCH study will examine whether these patients benefit from a restrictive administration of coagulation products.

Timeline

Start
2023-01-19
Primary completion
2027-01-01
Completion
2027-03-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Platelet Concentrate Other / unclassified
Comparator Prothrombin Complex Concentrate Protein / enzyme biologic 10 iu/kg

Indications